Cytek Biosciences (CTKB) FCF Margin (2020 - 2026)
Cytek Biosciences (CTKB) reported FCF Margin of 9.16% for Q1 2026, down 681.0% on a YoY basis from 1.58% in Q1 2025, and down 598.63% quarter-over-quarter from 1.31% in Q4 2025.
Cytek Biosciences (CTKB) FCF Margin (2020 - 2026) Analysis & Trends
Cytek Biosciences has reported FCF Margin for 7 years, with the latest figure at 9.16% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 681.0% year-over-year to 9.16%; the trailing twelve-month figure through Mar 2026 stood at 3.86% (down 1430.0% YoY), and the FY2025 full-year result was 2.39%, down 1496.0% from the prior year.
- FCF Margin for Q1 2026 stood at 9.16%, down from 1.31% in the prior quarter.
- The five-year high for FCF Margin was 28.63% in Q3 2024, with the low at 22.19% in Q2 2022.
- Historically, FCF Margin has averaged 0.26% across 5 years, with a median of 2.35% in 2025.
- Annual changes were most pronounced in 2024 — FCF Margin soared 3759 bps — and 2025, when it plunged 3160 bps.
- Cytek Biosciences' FCF Margin stood at 10.02% in 2022, then fell by 15 bps to 8.52% in 2023, then tumbled by 61 bps to 3.34% in 2024, then sank by 139 bps to 1.31% in 2025, then slumped by 599 bps to 9.16% in 2026.
- The last three FCF Margin figures came in at 9.16% (Q1 2026), 1.31% (Q4 2025), and 2.98% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.44% |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | -9.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.16% |
| Dec 31, 2025 | -1.31% |
| Sep 30, 2025 | -2.98% |
| Jun 30, 2025 | -3.22% |
| Mar 31, 2025 | -2.35% |
| Dec 31, 2024 | 3.34% |
| Sep 30, 2024 | 28.63% |
| Jun 30, 2024 | 10.45% |
| Mar 31, 2024 | 8.18% |
| Dec 31, 2023 | 8.52% |
| Sep 30, 2023 | -8.97% |
| Jun 30, 2023 | -4.78% |
| Mar 31, 2023 | 6.34% |
| Dec 31, 2022 | 10.02% |
| Sep 30, 2022 | -18.50% |
| Jun 30, 2022 | -22.19% |
| Mar 31, 2022 | -6.45% |
| Dec 31, 2021 | -6.47% |
| Sep 30, 2021 | 3.46% |
| Jun 30, 2021 | -12.31% |